• Facebook
  • Twitter
  • LinkedIn
  • Google +
  • RSS

Kura Oncology - Articles and news items

First patient dosed in Phase 2 study of tipifarnib in advanced cancers with HRAS mutations

Industry news / 18 May 2015 / Victoria White

The first patient has been dosed in the Phase 2 clinical trial of tipifarnib in patients with locally advanced tumours that carry HRAS mutations…

 

Webinar: Understanding ISO Standards: ISO 14644-2:2015 Cleanroom MonitoringWATCH NOW
+ +